top of page

 
業績｜論文・出版物｜目次｜
 

2023

Treatment of human pancreatic cancers following local and systemic administration of oncolytic adenovirus serotype 35.

Ono R., Takayama K., Onishi R., Tokuoka S., Sakurai F., Mizuguchi H.

Anticancer Res., 43, 537-546 (2023)

PubMed

Biliary epithelial cell differentiation of bipotent human liver-derived organoids by 2D and 3D culture.

Tong Y., Ueyama-Toba Y., Mizuguchi H.

Biochem. Biophys. Rep., 33, 101432 (2023)

PubMed

Pre-treatment of oncolytic reovirus improves tumor accumulation and intratumoral distribution of PEG-liposomes.

Eguchi M., Hirata S., Ishigami I., Shuwari N., Ono R., Tachibana M., Tanuma M., Kasai A., Hashimoto H., Ogawara KI., Mizuguchi H., Sakurai F.

J. Cont. Rel., 354, 35-44 (2023)

PubMed

Establishment of MDR1-knockout human enteroids for pharmaceutical application

Inu T., Nomoto R., Yokota J., Yamashita T., Okada K., Kishimoto W., Nakase H., Mizuguchi H.

Drug Metab Pharmacokinet, 48, 100476 (2023)

PubMed

腫瘍溶解性ウイルスによる抗腫瘍免疫の活性化とがん免疫療法との併用

櫻井文教、水口裕之

ドラックデリバリーシステム, 38, 24-30 (2023)

WebSite
bottom of page